SEQUENTIAL ANTI-CTLA4 AND TARGETED IL-2 THERAPY

摘要

The invention provides a blocking ligand specific for CTLA-4 and a vascular targeting ligand/IL-2 complex, for sequential use in inhibiting the growth of tumor cell.